Data search


search
Exact
Search

Results for MligTC455_23006

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_23006 48 1.00 Mlig455_001776

Neo: -

Age: logFC(26M/2M)=-0.676

Mlig455_001776 {REF} {Length: 2604} {RNA1310_41105} {RNA815_50956}

Cumulative graph for MligTC455_23006

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -6.169 1.283 1.00000 1.00000
RegionR2 3.662 1.283 0.00936 0.09653
RegionR3 -0.558 1.283 0.89230 1.00000
RegionR4 0.987 1.283 0.37542 0.69927
RegionR5 1.875 1.283 0.08828 0.27983
RegionR6 2.106 1.283 0.09808 0.57540
RegionR7 -3.342 1.283 1.00000 1.00000
RegionR8 1.439 1.283 0.39000 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 1.2 1.283 0.99989 1.00000
RegenerationR2 0.206 1.283 0.75785 0.97593
RegenerationR3 -0.091 1.283 0.73536 0.95921
RegenerationR4 -0.18 1.283 0.87454 1.00000
RegenerationR5 -0.232 1.283 0.79021 0.98548
RegenerationR6 -1.101 1.283 0.38156 0.72234
RegenerationBL 2.202 1.283 0.17126 0.49623
RegenerationTP 1.919 1.283 0.37358 0.81077


Genes with expression patterns similar to MligTC455_23006

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_23006 48 1 Mlig455_001776

Neo: -

Age: logFC(26M/2M)=-0.676

5 1.000 1.000 1.000 - 1.000 1.000 Mlig455_001776 {REF} {Length: 2604} {RNA1310_41105} {RNA815_50956}
2. MligTC455_19917 83 1.72 Mlig455_057932, Mlig455_057967

Neo: -

Age: -

2.844 - - 0.916 - 0.984 0.944

Mlig455_057932 {REF} {Length: 2189} {RNA1310_65401} {RNA815_48417}

Mlig455_057967 {REF} {Length: 1876} {RNA1310_65401} {RNA815_48417}
3. MligTC455_44159 80 1.67 Mlig455_019040, Mlig455_055663

Neo: -

Age: Down-Up-Up

ADRB1, GALR3 2.587 - - 0.792 - 0.956 0.839

Mlig455_019040 {REF} {Length: 1804} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=31.3]} {Human: ENSG00000043591, ADRB1, adrenoceptor beta 1, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=47.8, Expect=1e-05]} {Dmel: FBgn0038874, ETHR, [Score=49.3, Expect=3e-06]} {Celegans: WBGene00017661, frpr-6, FMRFamide Peptide Receptor family, [Score=54.3, Expect=5e-08]} {Smed: dd_Smed_v6_19933_0_1, dd_Smed_v6_19933_0_1, [RH, Score=124, Expect=9e-33]} {RNA1310_47955} {RNA815_45615}

Mlig455_055663 {REF} {Length: 1667} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.2]} {Human: ENSG00000128310, GALR3, galanin receptor 3, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_14726_0_1, dd_Smed_v6_14726_0_1, [Score=103, Expect=6e-25]} {RNA1310_86586} {RNA815_45615}
4. MligTC455_19252 1355 28.24 Mlig455_054908, Mlig455_065614, Mlig455_065623

Neo: -

Age: Down-Down-Up

Region-enriched R2: 4.927/0.00706

QPCT 2.565 - - 0.863 - 0.960 0.742

Mlig455_054908 {REF} {Length: 1427} {Pfam: Peptidase family M28 [PF04389.19, score=84.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=113, Expect=3e-28]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=123, Expect=8e-32]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=116, Expect=7e-30]} {Celegans: WBGene00010418, H27A22.1, [Score=124, Expect=6e-33]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=118, Expect=1e-30]} {RNA1509_35784} {RNA1310_28475}

Mlig455_065614 {REF} {Length: 1515} {Pfam: Peptidase family M28 [PF04389.19, score=121.0]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=157, Expect=2e-44]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=162, Expect=2e-46]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=161, Expect=6e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=158, Expect=2e-45]} {Celegans: WBGene00010418, H27A22.1, [Score=166, Expect=2e-48]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=156, Expect=2e-44]} {RNA1509_35784} {RNA1310_28475, RNA1509_35784}

Mlig455_065623 {REF} {Length: 1295} {Pfam: Peptidase family M28 [PF04389.19, score=121.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=158, Expect=6e-45]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=162, Expect=2e-46]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=161, Expect=3e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=154, Expect=8e-44]} {Celegans: WBGene00010418, H27A22.1, [Score=163, Expect=2e-47]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=154, Expect=8e-44]} {RNA1509_35784} {RNA1310_28475}
5. MligTC455_28586 32 0.66 Mlig455_032084

Neo: -

Age: Up-Down-Down

2.513 - - 0.770 - 0.769 0.974 Mlig455_032084 {REF} {Length: 7595} {RNA1509_42521, RNA1509_44223, RNA1509_46209} {RNA1310_31499, RNA1509_42521, RNA1509_46209} {RNA1509_42521, RNA1509_46209, RNA815_19070}
6. MligTC455_27918 42 0.87 Mlig455_004025, Mlig455_004105, Mlig455_039294

Neo: -

Age: Down-Up-Up

2.464 0.723 - 0.784 - 0.957 -

Mlig455_004025 {REF} {Length: 2650} {RNA1310_16141} {RNA815_7007}

Mlig455_004105 {REF} {Length: 1268} {RNA1310_85247} {RNA815_59251}

Mlig455_039294 {REF} {Length: 2639} {RNA1310_16141} {RNA815_7007}
7. MligTC455_19049 17 0.34 Mlig455_049572

Neo: -

Age: -

Region-enriched R2: 8.023/0.01333

1.938 - - 0.974 - 0.964 - Mlig455_049572 {REF} {Length: 1581} {Pfam: Spt20 family [PF12090.10, score=18.3]}
8. MligTC455_09874 31 0.65 Mlig455_045071

Neo: -

Age: -

DOC2A 1.934 - - 0.965 - 0.969 - Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844}
9. MligTC455_54305 43 0.89 Mlig455_035878, Mlig455_035917

Neo: -

Age: -

ZC3H10 1.918 - - 0.963 - 0.955 -

Mlig455_035878 {REF} {Length: 2474} {tRNA: Val(CAC),pseudo, score=28.9} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414}

Mlig455_035917 {REF} {Length: 2428} {tRNA: Val(CAC),pseudo, score=30.2} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414}
10. MligTC455_29587 14 0.29 Mlig455_044070

Neo: -

Age: -

1.913 - - 0.924 - 0.989 - Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621}
11. MligTC455_49818 37 0.78 Mlig455_007221, Mlig455_007455

Neo: -

Age: -

1.908 - - 0.936 - - 0.972

Mlig455_007221 {REF} {Length: 2050} {RNA1310_53527} {RNA815_61088}

Mlig455_007455 {REF} {Length: 3769} {Mouse: ENSMUSG00000054999, Naaladl1, N-acetylated alpha-linked acidic dipeptidase-like 1, [Score=56.6, Expect=8e-08]} {RNA1310_53527} {RNA815_58531}
12. MligTC455_53869 27 0.57 Mlig455_060247

Neo: -

Age: -

CHDH 1.908 - - 0.969 - 0.939 - Mlig455_060247 {REF} {Length: 2837} {Pfam: GMC oxidoreductase [PF00732.21, score=82.3]; GMC oxidoreductase [PF05199.15, score=61.5]; FAD dependent oxidoreductase [PF01266.26, score=20.3]; Lycopene cyclase protein [PF05834.14, score=18.0]} {Human: ENSG00000016391, CHDH, choline dehydrogenase, [Score=101, Expect=6e-22]} {Mouse: ENSMUSG00000015970, Chdh, choline dehydrogenase, [Score=103, Expect=9e-23]} {Dmel: FBgn0037896, ninaG, [Score=116, Expect=3e-27]} {Celegans: WBGene00007917, C34C6.4, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_13047_0_2, dd_Smed_v6_13047_0_2, [RH, Score=166, Expect=2e-44]} {RNA1310_47881.1}
13. MligTC455_53461 15 0.31 Mlig455_007127

Neo: -

Age: -

PLCE1 1.907 - - 0.962 - 0.945 - Mlig455_007127 {REF} {Length: 9858} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=203.6]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=104.3]; FERM central domain [PF00373.20, score=30.1]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.4]; C2 domain [PF00168.32, score=24.5]; RasGEF domain [PF00617.21, score=24.5]; Ras association (RalGDS/AF-6) domain [PF00788.25, score=20.8]} {Human: ENSG00000138193, PLCE1, phospholipase C epsilon 1, [Score=530, Expect=8e-152]} {Mouse: ENSMUSG00000024998, Plce1, phospholipase C, epsilon 1, [Score=524, Expect=4e-150]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=161, Expect=4e-39]} {Celegans: WBGene00004036, plc-1, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, [Score=436, Expect=1e-123]} {Smed: dd_Smed_v6_9716_1_1, dd_Smed_v6_9716_1_1, [Score=507, Expect=8e-145]} {RNA1310_38856} {RNA815_52816}
14. MligTC455_51881 14 0.3 Mlig455_047149, Mlig455_047294

Neo: -

Age: -

CHAC1 1.905 - - 0.941 - 0.964 -

Mlig455_047149 {REF} {Length: 1045} {Pfam: ChaC-like protein [PF04752.14, score=137.0]} {Human: ENSG00000128965, CHAC1, ChaC glutathione specific gamma-glutamylcyclotransferase 1, [Score=134, Expect=5e-39]} {Mouse: ENSMUSG00000027313, Chac1, ChaC, cation transport regulator 1, [Score=133, Expect=1e-38]} {Dmel: FBgn0039109, CG10365, [Score=112, Expect=5e-30]} {Celegans: WBGene00017724, F22F7.7, Gamma-glutamylcyclotransferase, [Score=108, Expect=9e-30]} {Smed: dd_Smed_v6_2439_0_1, dd_Smed_v6_2439_0_1, [Score=155, Expect=1e-47]} {RNA1310_83351}

Mlig455_047294 {REF} {Length: 1073} {Pfam: ChaC-like protein [PF04752.14, score=166.0]} {Human: ENSG00000128965, CHAC1, ChaC glutathione specific gamma-glutamylcyclotransferase 1, [RH, Score=153, Expect=6e-46]} {Mouse: ENSMUSG00000027313, Chac1, ChaC, cation transport regulator 1, [RH, Score=150, Expect=6e-45]} {Dmel: FBgn0039109, CG10365, [Score=131, Expect=5e-37]} {Celegans: WBGene00017724, F22F7.7, Gamma-glutamylcyclotransferase, [RH, Score=126, Expect=9e-36]} {Smed: dd_Smed_v6_2439_0_1, dd_Smed_v6_2439_0_1, [Score=182, Expect=2e-57]} {RNA1310_83351}
15. MligTC455_40406 59 1.23 Mlig455_062481

Neo: -

Age: -

CHRNA9 1.904 - - 0.930 - 0.974 - Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3}
16. MligTC455_37058 19 0.4 Mlig455_061075

Neo: -

Age: -

1.901 - - 0.967 - 0.934 - Mlig455_061075 {REF} {Length: 4598} {Pfam: IQ calmodulin-binding motif [PF00612.29, score=31.8]} {RNA1509_56135} {RNA1310_6435} {RNA815_17633}
17. MligTC455_37701 47 0.98 Mlig455_029831

Neo: -

Age: -

Region-enriched R2: 8.298/0.02665

1.901 - - 0.925 - 0.976 - Mlig455_029831 {REF} {Length: 724} {RNA1310_73844}
18. MligTC455_35813 35 0.73 Mlig455_013562, Mlig455_013615

Neo: -

Age: -

Region-enriched R2: 7.733/0.00085

NPR2 1.901 - - 0.954 - 0.947 -

Mlig455_013562 {REF} {Length: 3105} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.6]; Nitrate and nitrite sensing [PF08376.12, score=108.9]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=247, Expect=6e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=1e-73]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=330, Expect=3e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=7e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_27869}

Mlig455_013615 {REF} {Length: 2993} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=187.7]; Nitrate and nitrite sensing [PF08376.12, score=109.5]; Heme NO binding associated [PF07701.16, score=29.1]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=251, Expect=2e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=246, Expect=8e-69]; ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=241, Expect=1e-66]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=252, Expect=9e-74]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=247, Expect=2e-69]} {Dmel: FBgn0053958, CG33958, [Score=331, Expect=1e-102]} {Celegans: WBGene00001533, gcy-6, Receptor-type guanylate cyclase gcy-6, [Score=231, Expect=8e-64]} {Smed: dd_Smed_v6_11767_0_1, dd_Smed_v6_11767_0_1, [Score=244, Expect=3e-68]} {RNA1310_16282} {RNA815_33407}
19. MligTC455_13434 15 0.3 Mlig455_025922

Neo: -

Age: -

1.898 - - 0.902 - 0.996 - Mlig455_025922 {REF} {Length: 1467} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=36.3]} {RNA1310_51631} {RNA815_34338}
20. MligTC455_32612 55 1.15 Mlig455_015630

Neo: -

Age: -

Region-enriched R2: 5.626/0.02523

ARX 1.898 - - - - 0.936 0.962 Mlig455_015630 {REF} {Length: 2012} {Pfam: Homeodomain [PF00046.31, score=83.5]} {Human: ENSG00000004848, ARX, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Mouse: ENSMUSG00000035277, Arx, aristaless related homeobox, [RH, Score=133, Expect=1e-34]} {Dmel: FBgn0000061, al, aristaless, [RH, Score=130, Expect=3e-34]} {Celegans: WBGene00044330, alr-1, AristaLess (Drosophila homeodomain) Related, [RH, Score=118, Expect=2e-30]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [Score=119, Expect=3e-33]} {RNA1310_42333.1} {RNA815_48205}
21. MligTC455_46452 134 2.79 Mlig455_048151

Neo: -

Age: -

Region-specific R2: 6.389

Region-enriched R2: 7.075/0.00014

Regeneration-downregulated R2: -3.162

Regeneration-depleted R2: -3.162

1.896 - - 0.920 - 0.976 - Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352}
22. MligTC455_49077 11 0.22 Mlig455_028465

Neo: -

Age: -

SCNN1B 1.894 - - 0.901 - 0.993 - Mlig455_028465 {REF} {Length: 1973} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=191.1]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=75.9, Expect=9e-14]} {Mouse: ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=65.9, Expect=6e-11]; ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=62.8, Expect=7e-10]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=70.1, Expect=2e-12]} {Smed: dd_Smed_v6_26855_0_1, dd_Smed_v6_26855_0_1, [Score=260, Expect=5e-79]} {RNA1310_116633}
23. MligTC455_13433 11 0.22 Mlig455_025860

Neo: -

Age: -

Region-enriched R2: 6.296/0.01497

1.892 - - 0.902 - 0.990 - Mlig455_025860 {REF} {Length: 1640} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=35.7]} {RNA1310_51631} {RNA815_34338}
24. MligTC455_14350 14 0.3 Mlig455_016300

Neo: -

Age: -

1.889 - - - - 0.964 0.925 Mlig455_016300 {REF} {Length: 889} {NoTransDecoderORF} {RNA1310_59231}
25. MligTC455_44025 591 12.31 Mlig455_050980

Neo: -

Age: -

Region-specific R2: 5.366

Region-enriched R2: 5.986/0.00000

1.886 - - 0.924 - 0.962 - Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904}
26. MligTC455_17178 54 1.12 Mlig455_067758

Neo: -

Age: -

Region-enriched R2: 7.471/0.00007

1.884 - - 0.910 - 0.974 - Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1}
27. MligTC455_48213 164 3.41 Mlig455_056285, Mlig455_056310

Neo: -

Age: -

Region-enriched R2: 5.079/0.00142

1.883 - 0.915 - - - 0.968

Mlig455_056285 {REF} {Length: 2259} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=140.9]} {Smed: dd_Smed_v6_22997_0_1, dd_Smed_v6_22997_0_1, [Score=85.1, Expect=2e-17]} {RNA1310_14535} {RNA815_31041}

Mlig455_056310 {REF} {Length: 1953} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=140.9]} {Smed: dd_Smed_v6_22997_0_1, dd_Smed_v6_22997_0_1, [Score=85.1, Expect=2e-17]} {RNA1310_14535} {RNA815_31041}
28. MligTC455_30463 95 1.98 Mlig455_000250, Mlig455_058521, Mlig455_058532

Neo: -

Age: -

1.882 - - 0.923 - 0.959 -

Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085}

Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085}

Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085}
29. MligTC455_21227 18 0.37 Mlig455_018373

Neo: -

Age: -

RGS6 1.876 - - 0.916 - 0.960 - Mlig455_018373 {REF} {Length: 2679} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=126.8]; Regulator of G protein signaling domain [PF00615.21, score=113.6]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=33.8]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=315, Expect=1e-99]; ENSG00000182901, RGS7, regulator of G protein signaling 7, [Score=310, Expect=5e-98]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=310, Expect=1e-97]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=305, Expect=4e-96]} {Dmel: FBgn0259927, CG42450, [Score=314, Expect=5e-93]} {Celegans: WBGene00001145, eat-16, [RH, Score=242, Expect=3e-72]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=392, Expect=8e-130]} {RNA1310_24067}
30. MligTC455_22869 61 1.28 Mlig455_039906, Mlig455_039942

Neo: -

Age: -

Region-enriched R2: 3.948/0.03818

HCRTR1 1.876 - - 0.899 - - 0.977

Mlig455_039906 {REF} {Length: 2770} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=99.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000121764, HCRTR1, hypocretin receptor 1, [Score=78.6, Expect=4e-15]} {Mouse: ENSMUSG00000028778, Hcrtr1, hypocretin (orexin) receptor 1, [Score=82.4, Expect=2e-16]} {Dmel: FBgn0025595, AkhR, Adipokinetic hormone receptor, [Score=54.7, Expect=9e-08]} {Celegans: WBGene00003808, npr-2, NeuroPeptide Receptor family, [Score=62.4, Expect=3e-10]} {Smed: dd_Smed_v6_16129_0_1, dd_Smed_v6_16129_0_1, [RH, Score=215, Expect=2e-65]} {RNA1310_40963.1}

Mlig455_039942 {REF} {Length: 1828} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=99.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.8]} {Human: ENSG00000121764, HCRTR1, hypocretin receptor 1, [Score=78.2, Expect=6e-15]} {Mouse: ENSMUSG00000028778, Hcrtr1, hypocretin (orexin) receptor 1, [Score=83.2, Expect=9e-17]} {Dmel: FBgn0025595, AkhR, Adipokinetic hormone receptor, [Score=54.7, Expect=9e-08]} {Celegans: WBGene00003808, npr-2, NeuroPeptide Receptor family, [Score=62.0, Expect=3e-10]} {Smed: dd_Smed_v6_16129_0_1, dd_Smed_v6_16129_0_1, [RH, Score=215, Expect=1e-65]} {RNA1310_40963.1}
31. MligTC455_33939 15 0.31 Mlig455_018477

Neo: Int S/G2/M

Age: Up-Down-Down, logFC(26M/2M)=-0.565

GUCY1B1 1.875 - - 0.920 - 0.955 - Mlig455_018477 {REF} {Length: 4178} {Pfam: Heme NO binding associated [PF07701.16, score=239.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=198.0]; Haem-NO-binding [PF07700.17, score=172.7]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=343, Expect=9e-106]} {Mouse: ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=350, Expect=4e-106]; ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=348, Expect=7e-108]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=622, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=530, Expect=2e-176]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=818, Expect=0.0]} {RNA1509_41885} {RNA1310_21359} {RNA815_6599.2}
32. MligTC455_46566 167 3.47 Mlig455_030556

Neo: -

Age: -

Region-enriched R2: 2.352/0.01128

1.874 - - 0.961 - 0.913 - Mlig455_030556 {REF} {Length: 2003} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=86.7, Expect=8e-19]} {RNA1509_3114} {RNA1310_34234} {RNA815_19594}
33. MligTC455_17363 62 1.28 Mlig455_003936

Neo: -

Age: -

1.868 - - 0.914 - 0.954 - Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646}
34. MligTC455_34987 27 0.56 Mlig455_031823, Mlig455_047624, Mlig455_047675

Neo: -

Age: -

KREMEN2 1.867 - - 0.907 - 0.960 -

Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434}

Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434}

Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434}
35. MligTC455_07705 6 0.13 Mlig455_012841

Neo: -

Age: -

1.866 - - 0.902 - 0.964 - Mlig455_012841 {REF} {Length: 1042} {Smed: dd_Smed_v6_38985_0_1, dd_Smed_v6_38985_0_1, [Score=54.3, Expect=9e-09]} {RNA1310_136328}
36. MligTC455_09442 12 0.24 Mlig455_065765

Neo: -

Age: -

GABBR2 1.865 - - 0.901 - 0.964 - Mlig455_065765 {REF} {Length: 2959} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=146.7]; Receptor family ligand binding region [PF01094.30, score=114.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=285, Expect=7e-82]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=280, Expect=4e-80]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=239, Expect=2e-65]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=222, Expect=1e-60]} {Smed: dd_Smed_v6_20665_0_1, dd_Smed_v6_20665_0_1, [Score=140, Expect=6e-34]} {RNA1509_58025} {RNA1310_57812} {RNA815_11540}
37. MligTC455_28719 17 0.36 Mlig455_029838

Neo: -

Age: -

1.864 - - 0.901 - 0.963 - Mlig455_029838 {REF} {Length: 2181} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=140.7]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=48.5, Expect=9e-06]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=90.1, Expect=4e-19]} {RNA1310_71846} {RNA815_38264}
38. MligTC455_10018 16 0.32 Mlig455_034726, Mlig455_067577

Neo: -

Age: -

GUCY2D, GUCY2F 1.861 - - 0.898 - 0.963 -

Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442}

Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378}
39. MligTC455_40227 12 0.26 Mlig455_010749

Neo: -

Age: -

GRIK2 1.86 - - 0.902 - 0.958 - Mlig455_010749 {REF} {Length: 2895} {Pfam: Ligand-gated ion channel [PF00060.28, score=133.1]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=95.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=57.0]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=306, Expect=6e-90]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=305, Expect=4e-89]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=303, Expect=1e-88]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=306, Expect=3e-90]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=303, Expect=2e-89]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=302, Expect=3e-88]} {Dmel: FBgn0039927, CG11155, [Score=291, Expect=2e-84]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=262, Expect=8e-75]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=336, Expect=1e-100]} {RNA1310_47182} {RNA815_48326}
40. MligTC455_04854 57 1.18 Mlig455_032030

Neo: -

Age: -

Region-enriched R2: 5.099/0.03475

1.857 - - 0.904 - 0.953 - Mlig455_032030 {REF} {Length: 1388} {RNA1310_84273}
41. MligTC455_15184 33 0.69 Mlig455_065087

Neo: -

Age: -

1.857 - - 0.903 - 0.954 - Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497}
42. MligTC455_36193 13 0.27 Mlig455_025794

Neo: -

Age: -

B3GNT4 1.855 - - 0.901 - 0.954 - Mlig455_025794 {REF} {Length: 3112} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=1e-20]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.2, Expect=3e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=89.7, Expect=1e-18]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726}
43. MligTC455_16846 158 3.3 Mlig455_051873

Neo: -

Age: Down-Up-Up

Region-enriched R2: 5.265/0.00110

PRSS33 1.854 - - 0.952 - 0.902 - Mlig455_051873 {REF} {Length: 1386} {Pfam: Trypsin [PF00089.28, score=189.9]; Domain of unknown function (DUF1986) [PF09342.13, score=27.5]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=154, Expect=4e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=125, Expect=2e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=3e-53]} {RNA1509_26566} {RNA1310_23561} {RNA815_9840}
44. MligTC455_20643 34 0.72 Mlig455_066722

Neo: -

Age: -

CHRNA6 1.854 - - 0.883 - 0.971 - Mlig455_066722 {REF} {Length: 3504} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=224.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.3]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=357, Expect=6e-118]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=355, Expect=6e-117]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=352, Expect=1e-115]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=340, Expect=1e-111]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=340, Expect=1e-111]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=358, Expect=2e-118]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=355, Expect=3e-117]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=345, Expect=4e-113]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=341, Expect=1e-111]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=435, Expect=1e-148]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=371, Expect=8e-124]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=570, Expect=0.0]} {RNA1509_52151} {RNA1310_16118} {RNA815_53101}
45. MligTC455_49296 69 1.44 Mlig455_034352, Mlig455_034414

Neo: -

Age: -

1.854 - - 0.959 - 0.895 -

Mlig455_034352 {REF} {Length: 912} {TRANSSPLICED}

Mlig455_034414 {REF} {Length: 919} {TRANSSPLICED}
46. MligTC455_12126 26 0.55 Mlig455_040946

Neo: -

Age: -

1.853 - - 0.861 - 0.992 - Mlig455_040946 {REF} {Length: 1894} {RNA1310_146540} {RNA815_59956}
47. MligTC455_40687 28 0.58 Mlig455_040563, Mlig455_062078

Neo: -

Age: -

PDE1C 1.851 - - 0.891 - 0.960 -

Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402}

Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704}
48. MligTC455_19547 11 0.23 Mlig455_068540

Neo: -

Age: -

CUBN 1.85 - - 0.974 - 0.876 - Mlig455_068540 {REF} {Length: 3105} {Pfam: CUB domain [PF00431.22, score=94.3]} {Human: ENSG00000107611, CUBN, cubilin, [Score=63.9, Expect=1e-09]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=64.3, Expect=5e-10]} {Dmel: FBgn0261262, CG42613, [Score=95.9, Expect=5e-20]} {Celegans: WBGene00010587, sol-2, SOL-2 protein; Suppressor Of Lurcher movement defect, [Score=105, Expect=6e-24]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=72.8, Expect=3e-13]} {RNA1310_54691}
49. MligTC455_49492 10 0.21 Mlig455_054890

Neo: -

Age: -

1.848 - - 0.884 - 0.964 - Mlig455_054890 {REF} {Length: 1524} {RNA1509_22234} {RNA1310_23973} {RNA815_10832}
50. MligTC455_09510 314 6.55 Mlig455_001134, Mlig455_042048

Neo: -

Age: -

Region-specific R2: 5.291

Region-enriched R2: 5.151/0.00029

1.845 - - 0.885 - 0.960 -

Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1}

Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1}
51. MligTC455_42580 98 2.04 Mlig455_014929, Mlig455_045199

Neo: -

Age: -

NKX2-2 1.845 - - 0.881 - 0.964 -

Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707}

Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707}
52. MligTC455_44954 1303 27.14 Mlig455_029595, Mlig455_070648

Neo: Int S/G2/M

Age: Down-Up-Up, logFC(26M/2M)=1.023

Region-specific R2: 8.846

Region-enriched R2: 10.764/0.00000

1.845 - - 0.889 - 0.956 -

Mlig455_029595 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871} {RNA1310_66833.2} {RNA815_41767}

Mlig455_070648 {REF} {Length: 484} {Pfam: Pancreatic hormone peptide [PF00159.20, score=30.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.4, Expect=3e-08]} {RNA1509_20871, RNA1509_39484} {RNA1310_66833.2, RNA1509_20871, RNA1509_39484} {RNA1509_20871, RNA1509_39484, RNA815_41767}
53. MligTC455_50694 602 12.54 Mlig455_058794, Mlig455_070066

Neo: -

Age: Down-Down-Up

Region-specific R2: 5.478

Region-enriched R2: 3.805/0.01454

1.845 - - 0.893 - 0.952 -

Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041}

Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041}
54. MligTC455_19249 90 1.86 Mlig455_054092

Neo: -

Age: Down-Up-Up

Region-enriched R2: 7.298/0.00139

1.844 - - 0.891 - 0.953 - Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076}
55. MligTC455_16646 14 0.29 Mlig455_038608

Neo: -

Age: -

HTR1A 1.843 - - 0.886 - 0.957 - Mlig455_038608 {REF} {Length: 1523} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=49.9]} {Human: ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=71.6, Expect=7e-16]} {Mouse: ENSMUSG00000021721, Htr1a, 5-hydroxytryptamine (serotonin) receptor 1A, [Score=68.2, Expect=7e-15]; ENSMUSG00000022705, Drd3, dopamine receptor D3, [Score=65.1, Expect=9e-14]} {Dmel: FBgn0038063, Octbeta2R, Octopamine beta2 receptor, [Score=72.0, Expect=3e-16]} {Celegans: WBGene00016872, dop-4, Dopamine receptor 4, [Score=60.8, Expect=1e-12]} {Smed: dd_Smed_v6_31134_0_1, dd_Smed_v6_31134_0_1, [Score=118, Expect=3e-33]} {RNA1509_58224} {RNA1310_114359} {RNA815_11051.1}
56. MligTC455_22402 31 0.64 Mlig455_012784

Neo: -

Age: -

1.841 - - 0.883 - 0.958 - Mlig455_012784 {REF} {Length: 1963} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Smed: dd_Smed_v6_43697_0_1, dd_Smed_v6_43697_0_1, [Score=84.3, Expect=4e-19]} {RNA1310_96760.2} {RNA815_54296}
57. MligTC455_21258 64 1.34 Mlig455_001143, Mlig455_001305

Neo: -

Age: -

FOXD4 1.837 - - - - 0.975 0.862

Mlig455_001143 {REF} {Length: 2344} {Pfam: Forkhead domain [PF00250.20, score=125.5]} {Human: ENSG00000170122, FOXD4, forkhead box D4, [RH, Score=197, Expect=1e-57]; ENSG00000187140, FOXD3, forkhead box D3, [RH, Score=196, Expect=6e-57]} {Mouse: ENSMUSG00000067261, Foxd3, forkhead box D3, [RH, Score=197, Expect=2e-57]; ENSMUSG00000116152, Foxd3, forkhead box D3, [RH, Score=197, Expect=2e-57]} {Dmel: FBgn0004896, fd59A, forkhead domain 59A, [RH, Score=210, Expect=8e-63]} {Celegans: WBGene00006853, unc-130, [RH, Score=207, Expect=4e-63]} {Smed: dd_Smed_v6_23249_0_1, dd_Smed_v6_23249_0_1, [RH, Score=223, Expect=2e-68]} {RNA1310_116948}

Mlig455_001305 {REF} {Length: 1757} {Pfam: Forkhead domain [PF00250.20, score=51.7]} {Human: ENSG00000170122, FOXD4, forkhead box D4, [Score=99.4, Expect=3e-22]; ENSG00000187140, FOXD3, forkhead box D3, [Score=96.3, Expect=5e-21]} {Mouse: ENSMUSG00000116152, Foxd3, forkhead box D3, [Score=96.7, Expect=2e-21]; ENSMUSG00000067261, Foxd3, forkhead box D3, [Score=96.7, Expect=2e-21]} {Dmel: FBgn0004896, fd59A, forkhead domain 59A, [Score=112, Expect=6e-27]} {Celegans: WBGene00006853, unc-130, [Score=115, Expect=7e-29]} {Smed: dd_Smed_v6_23249_0_1, dd_Smed_v6_23249_0_1, [Score=124, Expect=2e-31]} {RNA1310_116948}
58. MligTC455_51386 763 15.89 Mlig455_041336, Mlig455_056222

Neo: -

Age: -

Region-enriched R2: 3.643/0.00016

HPGDS 1.836 - - 0.882 - 0.954 -

Mlig455_041336 {REF} {Length: 1363} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=46.9]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.3]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.4]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=74.7, Expect=2e-15]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00001756, gst-8, Probable glutathione S-transferase 8, [Score=92.8, Expect=2e-22]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=79.0, Expect=2e-17]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778}

Mlig455_056222 {REF} {Length: 1343} {Pfam: Glutathione S-transferase, C-terminal domain [PF14497.8, score=62.1]; Glutathione S-transferase, N-terminal domain [PF02798.22, score=34.8]; Glutathione S-transferase, C-terminal domain [PF00043.27, score=31.1]; Glutathione S-transferase, N-terminal domain [PF13409.8, score=23.4]; Glutathione S-transferase, N-terminal domain [PF13417.8, score=22.5]; Glutathione S-transferase, C-terminal domain [PF13410.8, score=21.8]} {Human: ENSG00000163106, HPGDS, hematopoietic prostaglandin D synthase, [Score=78.2, Expect=8e-17]} {Mouse: ENSMUSG00000029919, Hpgds, hematopoietic prostaglandin D synthase, [Score=85.5, Expect=1e-19]} {Celegans: WBGene00001750, gst-2, Glutathione S-transferase 2, [RH, Score=96.7, Expect=3e-24]} {Smed: dd_Smed_v6_1206_0_1, dd_Smed_v6_1206_0_1, [Score=84.3, Expect=2e-19]} {RNA1509_56224} {RNA1310_31890.2} {RNA815_14778}
59. MligTC455_12867 14 0.29 Mlig455_049571

Neo: -

Age: -

KCNIP3 1.835 - - 0.875 - 0.960 - Mlig455_049571 {REF} {Length: 1857} {Pfam: EF-hand domain pair [PF13499.8, score=50.8]; EF hand [PF00036.34, score=44.5]; EF-hand domain [PF13405.8, score=39.6]; EF-hand domain pair [PF13833.8, score=32.7]; EF hand [PF13202.8, score=30.8]} {Human: ENSG00000115041, KCNIP3, potassium voltage-gated channel interacting protein 3, [Score=155, Expect=4e-44]; ENSG00000120049, KCNIP2, potassium voltage-gated channel interacting protein 2, [Score=148, Expect=1e-41]} {Mouse: ENSMUSG00000025221, Kcnip2, Kv channel-interacting protein 2, [Score=146, Expect=4e-41]; ENSMUSG00000053519, Kcnip1, Kv channel-interacting protein 1, [Score=140, Expect=7e-39]} {Dmel: FBgn0265595, CG44422, [Score=154, Expect=3e-42]} {Celegans: WBGene00003563, ncs-1, Neuronal calcium sensor 1, [Score=125, Expect=1e-33]} {Smed: dd_Smed_v6_9434_0_1, dd_Smed_v6_9434_0_1, [Score=127, Expect=2e-34]} {RNA1310_70106} {RNA815_36691}
60. MligTC455_16476 126 2.63 Mlig455_042936

Neo: -

Age: -

Region-enriched R2: 3.045/0.04509

1.835 - - 0.879 - 0.956 - Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221}
61. MligTC455_14898 41 0.86 Mlig455_011988

Neo: -

Age: -

1.829 - - 0.865 - 0.964 - Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1}
62. MligTC455_49919 745 15.52 Mlig455_017182, Mlig455_048150

Neo: -

Age: -

Region-specific R2: 7.180

Region-enriched R2: 7.978/0.00000

Regeneration-downregulated R2: -4.649

Regeneration-depleted R2: -4.649

1.829 - - 0.876 - 0.953 -

Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347}

Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347}
63. MligTC455_32367 163 3.39 Mlig455_056139, Mlig455_058755

Neo: Irradiation

Age: logFC(26M/2M)=0.857

Region-enriched R2: 5.313/0.01588
Region-enriched R5: 4.811/0.00002

PI16 1.827 - - 0.950 - 0.877 -

Mlig455_056139 {REF} {Length: 1952} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=52.2]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=89.7, Expect=7e-19]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0038126, CG8483, [Score=66.2, Expect=1e-11]} {Celegans: WBGene00003055, lon-1, LONg, [RH, Score=80.9, Expect=7e-17]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=138, Expect=8e-36]} {RNA1310_31832.1} {RNA815_50399}

Mlig455_058755 {REF} {Length: 1144} {RNA1310_31832.1} {RNA815_50399}
64. MligTC455_53720 144 2.99 Mlig455_028516

Neo: -

Age: -

Region-enriched R2: 4.205/0.01762

CTBP2 1.827 - - 0.875 - 0.952 - Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484}
65. MligTC455_50931 28 0.58 Mlig455_046985, Mlig455_047028

Neo: -

Age: -

FCN2 1.826 - - 0.863 - 0.963 -

Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881}

Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881}
66. MligTC455_01456 250 5.2 Mlig455_019058, Mlig455_064312, Mlig455_064345

Neo: -

Age: -

PCSK5 1.825 - 0.872 - - - 0.953

Mlig455_019058 {REF} {Length: 290} {Human: ENSG00000099139, PCSK5, proprotein convertase subtilisin/kexin type 5, [Score=43.5, Expect=2e-06]}

Mlig455_064312 {REF} {Length: 641}

Mlig455_064345 {REF} {Length: 860} {Human: ENSG00000099139, PCSK5, proprotein convertase subtilisin/kexin type 5, [Score=48.5, Expect=3e-08]}
67. MligTC455_40388 23 0.47 Mlig455_019615

Neo: -

Age: -

1.825 - - 0.862 - 0.963 - Mlig455_019615 {REF} {Length: 2102} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=144, Expect=9e-37]} {RNA1310_29891} {RNA815_15562}
68. MligTC455_43261 41 0.86 Mlig455_065982

Neo: -

Age: -

1.824 - - 0.830 - 0.994 - Mlig455_065982 {REF} {Length: 581} {RNA1509_55651} {RNA1310_59019} {RNA815_42240}
69. MligTC455_48692 15 0.32 Mlig455_021398

Neo: -

Age: -

Region-enriched R2: 8.096/0.02429

1.824 - - 0.867 - 0.957 - Mlig455_021398 {REF} {Length: 1571} {Pfam: Ankyrin repeat [PF00023.32, score=20.9]; Ankyrin repeats (many copies) [PF13637.8, score=20.4]; Ankyrin repeats (many copies) [PF13857.8, score=19.6]; Ankyrin repeats (3 copies) [PF12796.9, score=19.4]} {Smed: dd_Smed_v6_29956_0_1, dd_Smed_v6_29956_0_1, [Score=54.7, Expect=3e-08]} {RNA1310_69005}
70. MligTC455_47780 214 4.46 Mlig455_018842, Mlig455_018853

Neo: -

Age: -

1.818 - - 0.843 - 0.975 -

Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082}

Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082}
71. MligTC455_20890 29 0.6 Mlig455_001461

Neo: -

Age: Down-Down-Up

1.817 - - 0.963 - 0.854 - Mlig455_001461 {REF} {Length: 2259} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=39.9]} {Smed: dd_Smed_v6_42201_0_1, dd_Smed_v6_42201_0_1, [Score=87.4, Expect=6e-19]} {RNA1310_44182}
72. MligTC455_14043 12 0.26 Mlig455_016776

Neo: -

Age: -

ANKRD63 1.816 - - 0.852 - 0.964 - Mlig455_016776 {REF} {Length: 1715} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=122.1]; Ankyrin repeats (many copies) [PF13637.8, score=70.6]; Ankyrin repeats (many copies) [PF13857.8, score=54.8]; Ankyrin repeat [PF00023.32, score=50.2]; Ankyrin repeat [PF13606.8, score=43.7]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=130, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=131, Expect=9e-34]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=66.2, Expect=3e-11]} {Celegans: WBGene00012124, T28D6.4, [Score=62.8, Expect=3e-10]} {Smed: dd_Smed_v6_11187_0_3, dd_Smed_v6_11187_0_3, [Score=56.6, Expect=2e-08]} {RNA815_38023}
73. MligTC455_05183 13 0.27 Mlig455_003637

Neo: -

Age: -

1.815 - - 0.851 - 0.964 - Mlig455_003637 {REF} {Length: 906} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [Score=57.0, Expect=8e-10]} {RNA1310_45613} {RNA815_17816.1}
74. MligTC455_36194 30 0.61 Mlig455_064360, Mlig455_064382

Neo: -

Age: -

B3GNT4 1.814 - - 0.861 - 0.953 -

Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726}

Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726}
75. MligTC455_10017 8 0.17 Mlig455_034677

Neo: -

Age: -

GUCY2F 1.81 - - 0.847 - 0.963 - Mlig455_034677 {REF} {Length: 4582} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.9]; Protein kinase domain [PF00069.27, score=72.7]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=633, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=641, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=708, Expect=0.0]} {RNA1310_64185}
76. MligTC455_51759 40 0.83 Mlig455_026782

Neo: -

Age: -

Region-enriched R4: 4.435/0.02831

CNBD2 1.806 - - 0.842 - 0.964 - Mlig455_026782 {REF} {Length: 2590} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=70.9]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=65.1, Expect=2e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=62.4, Expect=1e-09]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0037837, CG14693, [RH, Score=53.9, Expect=3e-07]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=58.9, Expect=8e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=171, Expect=1e-45]} {RNA1310_33768} {RNA815_47620}
77. MligTC455_31272 74 1.54 Mlig455_017539

Neo: -

Age: Down-Up-Down

JMJD6 1.805 - - 0.841 - - 0.964 Mlig455_017539 {REF} {Length: 3500} {Pfam: Cupin-like domain [PF13621.8, score=83.9]; JmjC domain, hydroxylase [PF02373.24, score=41.2]; Cupin superfamily protein [PF08007.14, score=22.9]} {Human: ENSG00000070495, JMJD6, jumonji domain containing 6, arginine demethylase and lysine hydroxylase, [Score=81.3, Expect=6e-16]} {Mouse: ENSMUSG00000056962, Jmjd6, jumonji domain containing 6, [Score=78.6, Expect=3e-15]} {Dmel: FBgn0038948, PSR, phosphatidylserine receptor, [Score=77.4, Expect=5e-15]} {Celegans: WBGene00004205, psr-1, Bifunctional arginine demethylase and lysyl-hydroxylase psr-1, [Score=88.2, Expect=8e-19]} {Smed: dd_Smed_v6_12267_0_1, dd_Smed_v6_12267_0_1, [RH, Score=326, Expect=2e-107]} {RNA1509_51449} {RNA1310_17984} {RNA815_15470}
78. MligTC455_48512 51 1.05 Mlig455_017421, Mlig455_017499, Mlig455_019276

Neo: -

Age: Up-Down-Up

P2RX4 1.804 - 0.839 0.965 - - -

Mlig455_017421 {REF} {Length: 2818} {Pfam: ATP P2X receptor [PF00864.21, score=338.4]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=251, Expect=4e-77]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=235, Expect=3e-71]; ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=225, Expect=2e-66]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=308, Expect=2e-98]} {RNA1509_56054} {RNA1310_21511} {RNA815_49085}

Mlig455_017499 {REF} {Length: 1386} {Pfam: ATP P2X receptor [PF00864.21, score=246.7]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=183, Expect=5e-53]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=179, Expect=6e-52]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=224, Expect=7e-68]} {RNA1509_56054} {RNA1310_21511} {RNA815_57738}

Mlig455_019276 {REF} {Length: 2742} {Pfam: ATP P2X receptor [PF00864.21, score=337.4]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=251, Expect=3e-77]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=235, Expect=3e-71]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=306, Expect=2e-97]} {RNA1509_56054} {RNA1310_21511} {RNA815_49085}
79. MligTC455_17633 25 0.51 Mlig455_066373

Neo: -

Age: -

RHBG 1.803 - - 0.839 - 0.964 - Mlig455_066373 {REF} {Length: 1855} {Pfam: Ammonium Transporter Family [PF00909.23, score=389.0]} {Human: ENSG00000132677, RHBG, Rh family B glycoprotein (gene/pseudogene), [Score=60.8, Expect=3e-09]} {Dmel: FBgn0038309, Amt, Ammonium transporter, [RH, Score=459, Expect=5e-157]} {Celegans: WBGene00000135, amt-3, Putative ammonium transporter 3, [RH, Score=401, Expect=1e-132]} {RNA1310_75971} {RNA815_45087}
80. MligTC455_22125 178 3.71 Mlig455_028579, Mlig455_028597

Neo: -

Age: -

Region-enriched R2: 5.949/0.00261

1.803 - - - - 0.829 0.974

Mlig455_028579 {REF} {Length: 993} {RNA1509_54214} {RNA1310_51652} {RNA815_36975}

Mlig455_028597 {REF} {Length: 962} {RNA1509_54214} {RNA1310_51652} {RNA815_36975}
81. MligTC455_32391 75 1.56 Mlig455_017179, Mlig455_048147

Neo: -

Age: -

SDCBP2 1.803 - - 0.816 - 0.987 -

Mlig455_017179 {REF} {Length: 3606} {Pfam: PDZ domain [PF00595.26, score=88.1]; PDZ domain [PF17820.3, score=72.4]; PDZ domain [PF13180.8, score=47.6]; Immunoglobulin domain [PF13927.8, score=44.1]; Immunoglobulin domain [PF00047.27, score=37.4]; Immunoglobulin V-set domain [PF07686.19, score=35.7]; Immunoglobulin I-set domain [PF07679.18, score=25.6]} {Human: ENSG00000125775, SDCBP2, syndecan binding protein 2, [Score=59.3, Expect=2e-09]; ENSG00000006611, USH1C, USH1 protein network component harmonin, [Score=56.6, Expect=2e-07]} {Mouse: ENSMUSG00000038298, Pdzk1, PDZ domain containing 1, [Score=60.1, Expect=8e-09]; ENSMUSG00000030838, Ush1c, USH1 protein network component harmonin, [Score=60.1, Expect=1e-08]; ENSMUSG00000027456, Sdcbp2, syndecan binding protein (syntenin) 2, [Score=59.3, Expect=5e-09]} {Dmel: FBgn0029835, CG5921, [Score=55.1, Expect=2e-07]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [Score=63.2, Expect=7e-10]} {Smed: dd_Smed_v6_21860_0_1, dd_Smed_v6_21860_0_1, [RH, Score=146, Expect=2e-38]} {RNA1509_22767} {RNA1310_28491} {RNA815_60114}

Mlig455_048147 {REF} {Length: 2119} {Pfam: Immunoglobulin domain [PF13927.8, score=47.4]; Immunoglobulin domain [PF00047.27, score=41.5]; Immunoglobulin V-set domain [PF07686.19, score=40.0]; Immunoglobulin I-set domain [PF07679.18, score=29.2]; Immunoglobulin domain [PF13895.8, score=25.4]} {RNA1509_22767} {RNA1310_34847}
82. MligTC455_49863 62 1.29 Mlig455_019320, Mlig455_019542

Neo: -

Age: -

SHOX2 1.802 - - 0.848 - 0.954 -

Mlig455_019320 {REF} {Length: 1251} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.2, Expect=5e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=7e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.2, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=84.0, Expect=2e-19]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055}

Mlig455_019542 {REF} {Length: 1249} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.6, Expect=4e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=6e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.6, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=86.7, Expect=3e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055}
83. MligTC455_15949 37 0.76 Mlig455_059880

Neo: -

Age: -

1.796 - - 0.808 - 0.988 - Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903}
84. MligTC455_28278 110 2.28 Mlig455_018484

Neo: -

Age: -

1.796 - 0.838 - - - 0.958 Mlig455_018484 {REF} {Length: 1124} {NoTransDecoderORF} {RNA1509_35077} {RNA1310_17510.1} {RNA815_9674}
85. MligTC455_28720 27 0.56 Mlig455_057010

Neo: -

Age: -

ASIC1 1.794 - - 0.831 - 0.963 - Mlig455_057010 {REF} {Length: 2468} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=174.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=62.4, Expect=1e-09]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=63.2, Expect=4e-10]} {Celegans: WBGene00016063, delm-2, DEgenerin Linked to Mechanosensation, [Score=53.1, Expect=3e-07]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=109, Expect=2e-25]} {RNA1310_71846} {RNA815_38264}
86. MligTC455_36698 41 0.85 Mlig455_020379, Mlig455_020438

Neo: -

Age: -

Region-enriched R4: 4.050/0.03458

1.794 - - 0.843 - 0.951 -

Mlig455_020379 {REF} {Length: 1748} {Celegans: WBGene00007723, C25F9.2, [Score=77.8, Expect=7e-17]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935}

Mlig455_020438 {REF} {Length: 2872} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=53.1]} {Celegans: WBGene00007723, C25F9.2, [Score=206, Expect=7e-57]} {RNA1509_21495} {RNA1310_13315} {RNA815_8935}
87. MligTC455_29261 34 0.71 Mlig455_024258

Neo: -

Age: -

1.793 - - 0.828 - 0.965 - Mlig455_024258 {REF} {Length: 1171} {RNA1509_25125} {RNA1310_234.1} {RNA815_23.1}
88. MligTC455_43390 28 0.59 Mlig455_064273

Neo: -

Age: Down-Up-Down

PRKAR2A 1.792 - - 0.842 - 0.950 - Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628}
89. MligTC455_53838 10 0.21 Mlig455_008156

Neo: -

Age: -

1.792 - - 0.828 - 0.964 - Mlig455_008156 {REF} {Length: 2378} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=7e-08]} {RNA1310_37888} {RNA815_29107}
90. MligTC455_15771 15 0.31 Mlig455_013616

Neo: -

Age: -

1.791 - - 0.818 - 0.973 - Mlig455_013616 {REF} {Length: 1678} {Pfam: Glycine rich protein [PF12810.9, score=28.8]} {RNA1509_48637} {RNA1310_55197} {RNA815_27869}
91. MligTC455_15183 10 0.2 Mlig455_018461

Neo: -

Age: Down-Up-Down

SCNN1A 1.787 - - 0.826 - 0.961 - Mlig455_018461 {REF} {Length: 2620} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.7]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=67.8, Expect=4e-11]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=55.5, Expect=6e-08]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.9, Expect=5e-12]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497}
92. MligTC455_15890 18 0.38 Mlig455_059636

Neo: -

Age: -

CD209 1.786 - - 0.822 - 0.964 - Mlig455_059636 {REF} {Length: 1223} {Pfam: Lectin C-type domain [PF00059.23, score=29.7]} {Human: ENSG00000090659, CD209, CD209 molecule, [Score=49.3, Expect=2e-06]} {Dmel: FBgn0040096, lectin-33A, [Score=48.9, Expect=6e-07]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=2e-12]} {RNA1509_20946} {RNA1310_53178} {RNA815_42043}
93. MligTC455_31521 35 0.73 Mlig455_055403

Neo: -

Age: -

PTGER4 1.786 - - 0.967 - 0.819 - Mlig455_055403 {REF} {Length: 4072} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=61.4]} {Human: ENSG00000171522, PTGER4, prostaglandin E receptor 4, [Score=134, Expect=3e-34]} {Mouse: ENSMUSG00000039942, Ptger4, prostaglandin E receptor 4 (subtype EP4), [Score=127, Expect=1e-31]} {RNA1509_56237} {RNA1310_37430} {RNA815_45788}
94. MligTC455_27678 355 7.4 Mlig455_070610

Neo: -

Age: -

Region-specific R2: 4.724

Region-enriched R2: 3.766/0.00062

1.781 - - 0.811 - 0.970 - Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024}
95. MligTC455_29100 53 1.11 Mlig455_022386, Mlig455_022475

Neo: -

Age: -

Region-enriched R2: 7.567/0.00114
Region-enriched R6: 6.070/0.00443

KREMEN2 1.781 - - 0.786 - 0.995 -

Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500}

Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500}
96. MligTC455_21291 27 0.57 Mlig455_009651

Neo: -

Age: -

1.779 - - 0.821 - 0.958 - Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115}
97. MligTC455_40340 201 4.19 Mlig455_021026, Mlig455_021062

Neo: -

Age: -

1.779 - - 0.820 - 0.959 -

Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069}

Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069}
98. MligTC455_47018 21 0.43 Mlig455_057664

Neo: -

Age: -

1.779 - - 0.972 - 0.807 - Mlig455_057664 {REF} {Length: 1530} {RNA1509_57646} {RNA1310_33223} {RNA815_39352}
99. MligTC455_50410 31 0.64 Mlig455_020239

Neo: -

Age: -

GRIA2 1.777 - - 0.786 - 0.991 - Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684}
100. MligTC455_52370 274 5.7 Mlig455_017817

Neo: -

Age: -

ACBD3 1.777 - 0.950 - - 0.827 - Mlig455_017817 {REF} {Length: 3060} {TRANSSPLICED} {Pfam: Golgi-dynamics membrane-trafficking [PF13897.8, score=210.0]} {Human: ENSG00000182827, ACBD3, acyl-CoA binding domain containing 3, [Score=193, Expect=4e-56]} {Mouse: ENSMUSG00000026499, Acbd3, acyl-Coenzyme A binding domain containing 3, [Score=187, Expect=3e-54]} {Dmel: FBgn0031061, CG14232, [Score=203, Expect=2e-60]} {Celegans: WBGene00012765, Y41E3.7, [RH, Score=252, Expect=4e-81]} {Smed: dd_Smed_v6_2498_0_1, dd_Smed_v6_2498_0_1, [RH, Score=301, Expect=5e-101]} {RNA1509_14041, RNA1509_58820} {RNA1310_22568, RNA1509_14041, RNA1509_58820} {RNA1509_14041, RNA1509_58820, RNA815_7615}

There are 515 more genes with r >= 0.95  Show all


Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA